Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (62)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Philips, Z.
Right arrow Articles by Posnett, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philips, Z.
Right arrow Articles by Posnett, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 1, 95-106, January 2000
© 2000 European Society of Human Reproduction and Embryology

Evaluation of the relative cost-effectiveness of treatments for infertility in the UK

Z. Philips1,2,3, M. Barraza-Llorens2 and J. Posnett2

1 Trent Institute for Health Services Research, University of Nottingham, Nottingham, NG7 2UH, 2 York Health Economics Consortium, University of York, Heslington, York, YO10 5DD, UK

This paper aims to complement existing clinical guidelines by providing evidence of the relative cost-effectiveness of treatments for infertility in the UK. A series of decision–analytical models have been developed to reflect current diagnostic and treatment pathways for the five main causes of infertility. Data to populate the models are derived from a systematic review and routine National Health Service activity data, and are augmented with expert opinion. Costs are derived from an analysis of extra-contractual referral tariffs and private sector data. Sensitivity analysis has been carried out to take account of the uncertainty of model parameters and to allow results to be interpreted in the light of local circumstances. Results of the modelling exercise suggest in-vitro fertilization is the most cost-effective treatment option for severe tubal factors and endometriosis, with surgery the most cost-effective in the case of mild or moderate disease. Ovulatory factors should be treated medically with the addition of laparoscopic ovarian diathermy in the presence of polycystic ovarian syndrome. For other causes, stimulated intrauterine insemination (unexplained and moderate male factor) and stimulated donor intrauterine insemination (severe male) are cost-effective.

Key words: assisted conception/cost-effectiveness/decision analysis/infertility/modelling

3 To whom correspondence should be addressed at Trent Institute for Health Services Research, University of Nottingham, Nottingham, NG7 2UH, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Obstetrician and GynaecologistHome page
D. Siassakos, S. Amber, and P. Wardle
Author's reply
Obstet Gynaecol (Lond), April 1, 2009; 11(2): 148 - 149.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
W. Ombelet, I. Cooke, S. Dyer, G. Serour, and P. Devroey
Infertility and the provision of infertility medical services in developing countries
Hum. Reprod. Update, November 1, 2008; 14(6): 605 - 621.
[Abstract] [Full Text] [PDF]


Home page
ESHRE MonogrHome page
W. Ombelet, R. Campo, E. Bosmans, and M. Nijs
Intrauterine insemination (IUI) as a first-line treatment in developing countries and methodological aspects that might influence IUI success
ESHRE Monogr, July 1, 2008; 2008(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
The Obstetrician and GynaecologistHome page
D. Siassakos, A. Syed, and P. Wardle
Tubal disease and assisted reproduction
Obstet Gynaecol (Lond), April 1, 2008; 10(2): 80 - 87.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S. Simoens, L. Hummelshoj, and T. D'Hooghe
Endometriosis: cost estimates and methodological perspective
Hum. Reprod. Update, July 1, 2007; 13(4): 395 - 404.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
E. J Adams, K. M E Turner, W J. Edmunds, T E Roberts, N Low, E. J Adams, W J. Edmunds, and K. M E Turner
The cost effectiveness of opportunistic chlamydia screening in England
Sex Transm Inf, July 1, 2007; 83(4): 267 - 275.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. Ombelet, G. Martens, P. De Sutter, J. Gerris, E. Bosmans, G. Ruyssinck, P. Defoort, G. Molenberghs, and W. Gyselaers
Perinatal outcome of 12 021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study
Hum. Reprod., April 1, 2006; 21(4): 1025 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. Somigliana, P. Vercellini, P. Vigano, G. Ragni, and P. G. Crosignani
Should endometriomas be treated before IVF-ICSI cycles?
Hum. Reprod. Update, January 1, 2006; 12(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
W. Ombelet, P. De Sutter, J. Van der Elst, and G. Martens
Multiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project
Hum. Reprod. Update, January 1, 2005; 11(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. J. Norman
Metformin--Comparison with Other Therapies in Ovulation Induction in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4797 - 4800.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
ESHRE Capri Workshop Group
Diagnosis and management of the infertile couple: missing information
Hum. Reprod. Update, July 1, 2004; 10(4): 295 - 307.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. A. Collins and A. Van Steirteghem
Overall prognosis with current treatment of infertility
Hum. Reprod. Update, July 1, 2004; 10(4): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A. Stewart
Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility: Should the guidelines be changed?
Hum. Reprod., May 1, 2003; 18(5): 903 - 907.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Collins
Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility: Current best evidence for the advanced treatment of unexplained subfertility
Hum. Reprod., May 1, 2003; 18(5): 907 - 912.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Garceau, J. Henderson, L.J. Davis, S. Petrou, L.R. Henderson, E. McVeigh, D.H. Barlow, and L.L. Davidson
Economic implications of assisted reproductive techniques: a systematic review
Hum. Reprod., December 1, 2002; 17(12): 3090 - 3109.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Miskry and M. Chapman
The use of intrauterine insemination in Australia and New Zealand
Hum. Reprod., April 1, 2002; 17(4): 956 - 959.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Ola, M. Afnan, K. Sharif, S. Papaioannou, N. Hammadieh, and C. L.R.Barratt
Should ICSI be the treatment of choice for all cases of in-vitro conception?: Considerations of fertilization and embryo development, cost ffectiveness and safety
Hum. Reprod., December 1, 2001; 16(12): 2485 - 2490.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
The ESHRE Capri Workshop Group
Social determinants of human reproduction
Hum. Reprod., July 1, 2001; 16(7): 1518 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Nargund, J. Waterstone, J.M. Bland, Z. Philips, J. Parsons, and S. Campbell
Cumulative conception and live birth rates in natural (unstimulated) IVF cycles
Hum. Reprod., February 1, 2001; 16(2): 259 - 262.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.